Does antithrombotic use enable earlier diagnosis of bladder cancer? A brief institutional assessment
Yash B. Shah1, Cassra B. Clark1,2, Andrew Shumaker1, Andrew A. Denisenko1, Samuel Alfonsi1, Zachary Prebay1, Joseph Schultz1, Vasil Mico1, Vishal Swaminathan1, Roy Wang1, James R. Mark1, Edouard J. Trabulsi1, Costas D. Lallas1, Mark J. Mann1, Hanan Goldberg3, Thenappan Chandrasekar1,*
Canadian Journal of Urology, Vol.29, No.6, pp. 11391-11393, 2022
Abstract Introduction: Wallis et al (JAMA 2017) demonstrated use of antithrombotic medications (ATMs) is associated with increased prevalence of hematuria-related complications and subsequent bladder cancer diagnosis within 6 months. Stage of diagnosis was lacking in this highly publicized study. This study examined the association of ATM use on bladder cancer stage at the time of diagnosis.
Materials and methods: We completed a retrospective chart review of patients with a bladder cancer diagnosis at our institution. Patient demographics and bladder cancer work up information were assessed. Patients were stratified based on use of ATMs at time diagnosis. Descriptive statistics… More >